BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17112628)

  • 1. Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection?
    Lau GK
    J Hepatol; 2007 Jan; 46(1):6-8. PubMed ID: 17112628
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.
    Lin SM; Yu ML; Lee CM; Chien RN; Sheen IS; Chu CM; Liaw YF
    J Hepatol; 2007 Jan; 46(1):45-52. PubMed ID: 17107734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic hepatitis B].
    Thimme R; Spangenberg HC; Blum HE
    Dtsch Med Wochenschr; 2008 Jan; 133(4):135-8. PubMed ID: 18197589
    [No Abstract]   [Full Text] [Related]  

  • 4. End points of therapy in chronic hepatitis B.
    Ahmed SN; Ecochard M; Zoulim F
    Expert Rev Gastroenterol Hepatol; 2010 Feb; 4(1):37-49. PubMed ID: 20136588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients co-infected with HBV and HCV.
    Coffin CS; Terrault NA
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):549-58. PubMed ID: 19485795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects].
    Isakov VA
    Eksp Klin Gastroenterol; 2007; (2):107-12. PubMed ID: 17539354
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of HBV-related cirrhosis.
    Vallet-Pichard A; Mallet V; Costentin CE; Pol S
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):527-35. PubMed ID: 19485793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging therapies of hepatitis B and C.
    Chen RY; Desmond PV; Locarnini SA
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S471-81. PubMed ID: 12534781
    [No Abstract]   [Full Text] [Related]  

  • 9. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
    Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
    J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halting the natural history of hepatitis B viral infection: a paradigm shift.
    Perrillo RP; Jacobson IM
    Semin Liver Dis; 2007 Aug; 27 Suppl 1():3-8. PubMed ID: 17701844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
    J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The natural history of HCV infection: the role of interferon therapy].
    Rumi MG; Romeo R
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):119-22. PubMed ID: 7542482
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of hepatocellular carcinoma.
    Wands JR
    N Engl J Med; 2004 Oct; 351(15):1567-70. PubMed ID: 15470221
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of antiviral therapy in the prevention of hepatocellular carcinoma.
    Franco J; Saeian K
    J Vasc Interv Radiol; 2002 Sep; 13(9 Pt 2):S191-6. PubMed ID: 12354836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus infection in children.
    Komatsu H; Inui A
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):427-50. PubMed ID: 25724218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update in the management of chronic hepatitis B.
    Asselah T; Marcellin P
    Clin Liver Dis; 2013 Aug; 17(3):ix-x. PubMed ID: 23905819
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of hepatocellular carcinoma.
    Craxì A; Cammà C
    Clin Liver Dis; 2005 May; 9(2):329-46, viii. PubMed ID: 15831277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and end-stage liver disease.
    Weisberg IS; Brown RS; Sigal SH
    Clin Liver Dis; 2007 Nov; 11(4):893-916, ix. PubMed ID: 17981234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant interferon therapy in Indian children with HBV related chronic liver disease.
    Guptan RC; Thakur V; Malhotra V; Sarin SK
    Indian Pediatr; 2002 May; 39(5):462-7. PubMed ID: 12037278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.